Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemomab Therapeutics Ltd.CMMB · Entity 7653 | Director | August 27, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemomab Therapeutics Ltd.
Report date August 27, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 33,000 |
Ending reported balance
After 2026-08-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-27 · Sale · Disposed 1,304 · Balance 34,000 Row 2 · 2026-08-28 · Sale · Disposed 1,000 · Balance 33,000 |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $52.80 · Expires 2030-07-16 | Direct | 172 |
Reported balance
After 2020-07-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-07-16 · Grant · Acquired 172 · Balance 172 F1: The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $109.04 · Expires 2031-04-19 | Direct | 3,143 |
Reported balance
After 2021-04-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-19 · Grant · Acquired 2,971 · Balance 3,143 F2: The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $14.12 · Expires 2032-03-07 | Direct | 4,848 |
Reported balance
After 2022-03-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-03-07 · Grant · Acquired 1,705 · Balance 4,848 F3: The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $6.48 · Expires 2033-03-21 | Direct | 6,562 |
Reported balance
After 2023-03-21 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-03-21 · Grant · Acquired 1,714 · Balance 6,562 F4: The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $2.96 · Expires 2034-03-18 | Direct | 9,082 |
Reported balance
After 2024-03-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-03-18 · Grant · Acquired 2,520 · Balance 9,082 F5: The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $6.16 · Expires 2035-03-16 | Direct | 12,903 |
Reported balance
After 2025-03-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-03-16 · Grant · Acquired 3,821 · Balance 12,903 F6: The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report. |
| Stock option (right to buy American Depositary Shares)SEC Table II · derivative / convertible security · Conversion / exercise price $2.14 · Expires 2036-03-16 | Direct | 18,075 |
Reported balance
After 2026-03-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-16 · Grant · Acquired 5,172 · Balance 18,075 |
Filing footnotes · ownership attribution and instrument terms
F1: The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report.
F2: The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report.
F3: The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report.
F4: The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report.
F5: The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report.
F6: The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | SaleAmerican Depositary Shares | 1,000 | $2.80 | $2,800.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · nonDerivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 Read SEC document |
| August 27, 2026 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | SaleAmerican Depositary Shares | 1,304 | $2.85 | $3,716.40 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Read SEC document |
| March 16, 2026 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 5,172 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 9 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,075 Underlying: American Depositary Shares · 5,172 shares Expires 2036-03-16 Read SEC document |
| March 16, 2025 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 3,821 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 8 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,903 Underlying: American Depositary Shares · 3,821 shares Expires 2035-03-16 F6 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report. Read SEC document |
| March 18, 2024 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 2,520 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 7 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,082 Underlying: American Depositary Shares · 2,520 shares Expires 2034-03-18 F5 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report. Read SEC document |
| March 21, 2023 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 1,714 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 6 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,562 Underlying: American Depositary Shares · 1,714 shares Expires 2033-03-21 F4 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report. Read SEC document |
| March 16, 2023 Filed Mar 23, 2023 11:35 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,875 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001178913-23-001111 · zk2329428.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,875 Underlying: American Depositary Shares · 6,875 shares Expires 2033-03-21 F3 · derivative.exercise_date: These options were granted as per the annual grant of options to directors. Those options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 12:53 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | SaleAmerican Depositary Shares | 2,409 | $2.00 | $4,818.00 |
DisclosureSEC source: 0001178913-22-004100 · zk2228788.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. F3 · balance_after: Based upon the 12,409 ADSs previously held as reported by Mr. Neil Cohen on Form 4 filed with the SEC on May 19, 2022. Read SEC document |
| May 18, 2022 Filed May 19, 2022 20:02 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,000 | $3.19 | $6,380.00 |
DisclosureSEC source: 0001178913-22-002093 · zk2227874.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,409 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. F3 · balance_after: Includes the previously reported 10,409 ADSs of the Company, as reported by Mr. Neil Cohen on Form 4 filed with the SEC on March 15, 2022. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,000 | $4.56 | $9,120.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · nonDerivative · entry 3 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,409 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,000 | $4.30 | $8,600.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · nonDerivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,409 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,000 | $4.20 | $8,400.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,409 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,820 | $0.00 Strike: $3.53 | $0.00 |
DisclosureSEC source: 0001178913-22-001022 · zk2227455.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: American Depositary Shares · 6,820 shares Expires 2032-03-07 F3 · derivative.exercise_date: These options vest and become exercisable in their entirety on March 16, 2023. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 07, 2022 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,820 | $0.00 Strike: $3.53 | $0.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · derivative · entry 4 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: American Depositary Shares · 6,820 shares Expires 2032-03-07 F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F4 · derivative.exercise_date: These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 07, 2022 Filed May 19, 2022 20:02 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,820 | $0.00 Strike: $3.53 | $0.00 |
DisclosureSEC source: 0001178913-22-002093 · zk2227874.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: American Depositary Shares · 6,820 shares Expires 2032-03-07 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F5 · derivative.exercise_date: These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 07, 2022 Filed Nov 18, 2022 12:53 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,820 | $0.00 Strike: $3.53 | $0.00 |
DisclosureSEC source: 0001178913-22-004100 · zk2228788.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: American Depositary Shares · 6,820 shares Expires 2032-03-07 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F5 · derivative.exercise_date: These options vest and become exercisable in their entirety on March 16, 2023 subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 07, 2022 Filed Mar 23, 2023 11:35 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 6,820 | $0.00 Strike: $3.53 | $0.00 |
DisclosureSEC source: 0001178913-23-001111 · zk2329428.xml · derivative · entry 3 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,820 Underlying: American Depositary Shares · 6,820 shares Expires 2032-03-07 F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F4 · derivative.exercise_date: These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 07, 2022 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 1,705 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 5 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,848 Underlying: American Depositary Shares · 1,705 shares Expires 2032-03-07 F3 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 12:29 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,000 | $7.43 | $14,860.00 |
DisclosureSEC source: 0001178913-21-003807 · ownership.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,409 F1 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. F2 · shares: The ADSs are held of record directly by the Phoenix Insurance Company Ltd. (Naftali Neil Cohen) (the "IRA"), which is self-managed by the Reporting Person. The Reporting person is the sole beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 21:06 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 11,884 | $0.00 Strike: $27.26 | $0.00 |
DisclosureSEC source: 0001104659-21-053223 · tm2113689-1_4.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Underlying: American Depositary Shares · 11,884 shares Expires 2031-04-19 F3 · derivative.exercise_date: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| April 19, 2021 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 11,884 | $0.00 Strike: $27.26 | $0.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · derivative · entry 5 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Underlying: American Depositary Shares · 11,884 shares Expires 2031-04-19 F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F5 · derivative.exercise_date: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| April 19, 2021 Filed May 19, 2022 20:02 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 11,884 | $0.00 Strike: $27.26 | $0.00 |
DisclosureSEC source: 0001178913-22-002093 · zk2227874.xml · derivative · entry 3 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Underlying: American Depositary Shares · 11,884 shares Expires 2031-04-19 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F6 · derivative.exercise_date: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| April 19, 2021 Filed Nov 18, 2022 12:53 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 11,884 | $0.00 Strike: $27.26 | $0.00 |
DisclosureSEC source: 0001178913-22-004100 · zk2228788.xml · derivative · entry 3 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Underlying: American Depositary Shares · 11,884 shares Expires 2031-04-19 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F6 · derivative.exercise_date: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| April 19, 2021 Filed Mar 23, 2023 11:35 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 11,884 | $0.00 Strike: $27.26 | $0.00 |
DisclosureSEC source: 0001178913-23-001111 · zk2329428.xml · derivative · entry 4 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,884 Underlying: American Depositary Shares · 11,884 shares Expires 2031-04-19 F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F5 · derivative.exercise_date: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| April 19, 2021 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 2,971 | $0.00 Strike: $109.04 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 4 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,143 Underlying: American Depositary Shares · 2,971 shares Expires 2031-04-19 F2 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report. Read SEC document |
| March 16, 2021 Filed Mar 26, 2021 14:27 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseOption to Purchase American Depositary Shares · Derivative | 688 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-21-042091 · tm2111044-1_4.xml · derivative · entry 2 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 Underlying: American Depositary Shares · 688 shares Expires 2030-03-15 F2 · derivative.exercise_date: These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service. Read SEC document |
| March 16, 2021 Filed Mar 26, 2021 14:27 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | PurchaseAmerican Depositary Shares | 2,409 | $41.51 | $99,997.59 |
DisclosureSEC source: 0001104659-21-042091 · tm2111044-1_4.xml · nonDerivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,409 F1 · shares: The Reporting Person acquired, in a private placement transaction, 1,397 American Depositary Shares and received an additional 1,011 American Depositary Shares pursuant to anti-dilution rights. Read SEC document |
| March 16, 2021 Filed Mar 15, 2022 20:07 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 688 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001178913-22-001117 · zk2227487.xml · derivative · entry 6 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 Underlying: American Depositary Shares · 688 shares Expires 2030-07-15 F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F6 · derivative.exercise_date: These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 16, 2021 Filed May 19, 2022 20:02 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 688 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001178913-22-002093 · zk2227874.xml · derivative · entry 4 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 Underlying: American Depositary Shares · 688 shares Expires 2030-07-15 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F7 · derivative.exercise_date: These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 16, 2021 Filed Nov 18, 2022 12:53 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 688 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001178913-22-004100 · zk2228788.xml · derivative · entry 4 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 Underlying: American Depositary Shares · 688 shares Expires 2030-07-15 F4 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F7 · derivative.exercise_date: These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| March 16, 2021 Filed Mar 23, 2023 11:35 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantOption to Purchase American Depositary Shares · Derivative | 688 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001178913-23-001111 · zk2329428.xml · derivative · entry 5 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688 Underlying: American Depositary Shares · 688 shares Expires 2030-07-15 F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F6 · derivative.exercise_date: These options vest and become exercisable as follows: 1/3 vested on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service. F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. Read SEC document |
| July 16, 2020 Filed Mar 11, 2021 23:33 UTC | Chemomab Therapeutics Ltd. ANCN · Entity 7653 | GrantStock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0001209191-21-019929 · doc4.xml · derivative · entry 1 Cohen Neil Harris · CIK 0001840006 · Director · interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Ordinary Shares · 55,000 shares Expires 2030-07-15 F1 · derivative.exercise_date: 25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter. Read SEC document |
| July 16, 2020 Filed Sep 1, 2026 14:05 UTC | Chemomab Therapeutics Ltd. CMMB · Entity 7653 | GrantStock option (right to buy American Depositary Shares) · Derivative | 172 | $0.00 Strike: $52.80 | $0.00 |
DisclosureSEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 3 Cohen Neil Harris · CIK 0001840006 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172 Underlying: American Depositary Shares · 172 shares Expires 2030-07-16 F1 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.